MatthewRCooperbergMDMPH, FACS
Urology • San Francisco, CASurgical Oncology
Helen Diller Family Professor, Department of Urology, UCSF
Dr. Cooperberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-476-4616Fax+1 415-514-6195
Education & Training
University of California (San Francisco)Residency, Urology, 2002 - 2008
Yale-New Haven Medical CenterInternship, Transitional Year, 2000 - 2001
Yale School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2026- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Pioneering Advances in Care and Education (PACE) Start of enrollment: 2018 Jul 19
Publications & Presentations
PubMed
- Contemporary Trends of Benign Prostatic Hyperplasia Procedures in the AUA Quality Registry: Are We Moving the Needle Toward More Minimally Invasive Treatments?Hiren V Patel, Benjamin N Breyer, Charles Jones, Rachel Mbassa, William Meeks 3rd
Urology Practice. 2025-01-01 - Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.Vinaik Mootha Sundaresan, Lindsey Webb, Maximilian Rabil, Aleksandra Golos, Ryan Sutherland
Urologic Oncology. 2024-12-19 - 3 citationsThe state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement.Juan Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, Karim Chamie, Samuel L Washington 3rd
Prostate Cancer and Prostatic Diseases. 2024-12-01
Journal Articles
- Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the USPeter E Lonergan, Matthew R Cooperberg, JAMA Network Open
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Atreya Dash, JAMA Oncology
- Join now to see all
Authored Content
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- The Diverse Genomic Landscape of Clinically Low-Risk Prostate CancerMay 2018
- A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsMay 2018
- Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsFebruary 2018
- How Should a Man with Prostate Cancer Choose His Surgeon?February 2018
- Join now to see all
Press Mentions
Why Some Prostate Cancers Shouldn’t Be Called ‘Cancer’October 29th, 2024- Should We Use the C-word for Mild Prostate Cancer?September 30th, 2024
- Powerful New Mini Microscopic Will Enable Precision Cancer SurgeryAugust 21st, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
